Similarly, inhibition of palmitoylation by 2-bromopalmitate and a synthetic peptide successfully induced decrease of PD-L1 expression and enhanced T-cell immunity against tumours in vitro and in vivo (87). This evidence concerns the gene CD274 and neoplasm.